Marta Garrote

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 80 citations · Full text

Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience

Pablo Mozas, Ferran Nadeu, Alfredo Rivas‐Delgado et al. · Blood Cancer Journal · 2020 · 34 citations · Full text

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán et al. · Blood Cancer Journal · 2021 · 33 citations · Full text

Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis

Gonzalo Gutiérrez, Jesús Z. Villarreal, Marta Garrote et al. · Bone Marrow Transplantation · 2020 · 29 citations

Transplantation, Kidney Transplant, Kidney Transplantation +7

Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

Alberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín et al. · Cancer · 2022 · 29 citations · Full text